Accordingly, constitutive NF-κB activation is a hallmark of most human cancers, where it drives tumor progression, disease recurrence, metastatic spread, and therapy resistance by inducing transcriptional programs that sustain cancer cell survival and proliferation and fuel tumor-promoting inflammation [6,18,19]. The gene discussed is NFKB1; the disease is cancer.